A combined 27.84 million equity shares representing 8.75 per cent of total equity of the Zydus Wellness changed hands on the NSE and BSE till 01:37 PM on Friday.
The average trading volumes on the ATGL counter jumped over 20-fold with a combined 16.44 million equity shares changing hands on the NSE and BSE till 01:16 PM.
Sun Pharma is transitioning its US business from low-margin generics to high-value specialty and innovative therapies.
Thus far in the calendar year 2026, TCS's market price plunged 23 per cent, as against 7.4 per cent decline in Nifty 50, data shows. The NIfty IT index lost over 1 per cent in trade on Tuesday.
In the past four trading days, the stock price of Natco Pharma has surged 10 per cent after the company announced the launch of Pomalidomide Capsules (generic of Pomalyst) in the US market.
Emcure Pharmaceuticals stock was quoting close to its 52-week high of ₹1,585.50 on Monday, and has surged up to 62% in the last one year.
Meesho said the Assessment Order along with the Demand Notice does not have any major adverse impact on the company's financial position, operations, or other activities.
On a quarter-on-quarter (Q-o-Q) basis, the company's net loss widened to ₹178.38 crore, as compared to a loss of ₹100.16 crore in Q2FY26
The management has maintained a double-digit volume growth forecast for Q4FY26 and FY27E, targeting 17-18 per cent EBITDA margin for Plumbing division and 12 -13 per cent for Paints & Adhesives.
Crisil Ratings believes that the Belrise group will maintain its strong position in the auto components industry backed by its established customer relationships and a diversified product portfolio.
Fractal Analytics reported a 10.5% rise in Q3 profit to ₹102.6 crore, with revenue up 21% year-on-year as healthcare, life sciences and BFS demand lifted its first post-listing results
Thus far in the calendar year 2026, BEL has outperformed the market by surging 16%, as compared to 6.6% decline in the BSE Sensex.
Acutaas Chemicals management has revised revenue guidance upwards from 25 per cent to around 30 per cent growth for FY26.
In the past one month, Lupin has outperformed the market by soaring 6 per cent, as against 4.5 per cent decline in the BSE Sensex.
Supported by solid demand, disciplined execution, and capex programs progressing as planned, Sai Life management remains confident in sustaining positive growth momentum.
In the past one month, the realty index has tanked 10 per cent, as against 6 per cent fall in the BSE Sensex.
There are hopes of a turnaround in overall corporate earnings after six quarters of single digit growth
Proptech firm Square Yards posted a 47 per cent year-on-year rise in Q3FY26 revenue, with Ebitda margin at 8 per cent and improved margins across business segments
The stock price of Swiggy slipped 5% and hit an all-time low of ₹285.85 on the BSE in Monday's intra-day, thus fell below its previous record low of ₹297 touched on May 13, 2025.
Out of the international order book of ₹3.57 trillion, around 75 per cent is from the Middle East, L&T said in the Q3 earnings conference call on January 28, 2026.